Resistance to therapy and metastasis, or the ability to expand outside the organ of origin, are key concerns in cancer because they give cancer the upper hand.
Texas [US], October 18 (ANI): The loss of ER expression in about one-fourth of recurrent oestrogen receptor-positive (ER+) breast cancer makes them immune to endocrine therapy and able to spread unchecked.